About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Mylan Arbitration Hearing Concluded

November 9, 2017

Click here to read more

Post navigation

Phosphagenics Entitlement Offer Raises Over AUD3M

Phosphagenics Provides Update on TPM Propofol Development Program

Related Posts

Phosphagenics Still Awaits SIAC Arbitration Update

June 8, 2018

Mylan Arbitration Update – expert report on quantum of damages claimed filed

May 29, 2017

Phosphagenics Placement Secures A$1.37 million

January 18, 2018

Recent Posts

Ethics Approval for CBD Topical Osteoarthritis Study
October 21, 2021
Dosing commences for Phase I human clinical trial
October 4, 2021
Biotech Webinar
September 23, 2021

Categories

Analyst Coverage
Company Announcement
Company Report
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.